Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program

AIMS/HYPOTHESIS: An increased risk of fracture with canagliflozin vs placebo was reported from the CANagliflozin cardioVascular Assessment Study (CANVAS) Program, with heterogeneity of findings identified between the two trials that comprise the CANVAS Program, CANVAS and CANVAS-R. The objective of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zien, Jardine, Meg, Perkovic, Vlado, Matthews, David R., Mahaffey, Kenneth W., de Zeeuw, Dick, Fulcher, Greg, Desai, Mehul, Oh, Richard, Simpson, Roger, Watts, Nelson B., Neal, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731200/
https://www.ncbi.nlm.nih.gov/pubmed/31399845
http://dx.doi.org/10.1007/s00125-019-4955-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731200/
https://www.ncbi.nlm.nih.gov/pubmed/31399845
http://dx.doi.org/10.1007/s00125-019-4955-5

Ejemplares similares